日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Risk Stratification for Trastuzumab-Induced Cardiac Dysfunction and Potential Implications for Surveillance

曲妥珠单抗诱发心脏功能障碍的风险分层及其对监测的潜在意义

Ali, Abdelrahman; Koutroumpakis, Efstratios; Song, Juhee; Booser, Daniel; Barcenas, Carlos H; Tripathy, Debu; Barac, Ana; Palaskas, Nicolas L; Deswal, Anita

Phase 1b study of combined selinexor and eribulin for the treatment of advanced solid tumors and triple-negative breast cancer

一项评估塞利尼索和艾立布林联合治疗晚期实体瘤和三阴性乳腺癌的1b期研究

Nelson, Blessie Elizabeth; Saleem, Sadia; Damodaran, Senthil; Somaiah, Neeta; Piha-Paul, Sarina; Moore, Julia Ann; Yilmaz, Bulent; Ogbonna, Deby; Karp, Daniel D; Dumbrava, Ecaterina; Tsimberidou, Apostolia M; Hong, David S; Rodon Ahnert, Jordi; Milton, Denái R; Zheng, Xiaofeng; Booser, Daniel J; Ibrahim, Nuhad K; Conley, Anthony P; Bhosale, Priya; Rojas Hernandez, Cristhiam M; Tripathy, Debasish; Naing, Aung; Meric-Bernstam, Funda

Short-Term Biomarker Modulation Study of Dasatinib for Estrogen Receptor-Negative Breast Cancer Chemoprevention

达沙替尼用于雌激素受体阴性乳腺癌化学预防的短期生物标志物调节研究

Akkoc Mustafayev, Fatma Nihan; Liu, Diane D; Gutierrez, Angelica M; Lewis, John E; Ibrahim, Nuhad K; Valero, Vicente; Booser, Daniel J; Litton, Jennifer K; Koenig, Kimberly; Yu, Dihua; Sneige, Nour; Arun, Banu K

SET(ER/PR): a robust 18-gene predictor for sensitivity to endocrine therapy for metastatic breast cancer

SET(ER/PR):一种可靠的18基因预测因子,用于预测转移性乳腺癌对内分泌治疗的敏感性

Sinn, Bruno V; Fu, Chunxiao; Lau, Rosanna; Litton, Jennifer; Tsai, Tsung-Heng; Murthy, Rashmi; Tam, Alda; Andreopoulou, Eleni; Gong, Yun; Murthy, Ravi; Gould, Rebekah; Zhang, Ya; King, Tari A; Viale, Agnes; Andrade, Victor; Giri, Dilip; Salgado, Roberto; Laios, Ioanna; Sotiriou, Christos; Marginean, Esmeralda C; Kwiatkowski, Danielle N; Layman, Rachel M; Booser, Daniel; Hatzis, Christos; Vicente Valero, V; Fraser Symmans, W

Inhibition of the phosphoinositide 3-kinase pathway for the treatment of patients with metastatic metaplastic breast cancer

抑制磷脂酰肌醇3-激酶通路治疗转移性化生性乳腺癌患者

Moulder, S; Helgason, T; Janku, F; Wheler, J; Moroney, J; Booser, D; Albarracin, C; Morrow, P K; Atkins, J; Koenig, K; Gilcrease, M; Kurzrock, R

A phase 1 study of weekly everolimus (RAD001) in combination with docetaxel in patients with metastatic breast cancer

一项针对转移性乳腺癌患者的每周依维莫司(RAD001)联合多西他赛的1期研究

Moulder, Stacy; Gladish, Gregory; Ensor, Joe; Gonzalez-Angulo, Ana Maria; Cristofanilli, Massimo; Murray, James L; Booser, Daniel; Giordano, Sharon H; Brewster, Abeena; Moore, Julia; Rivera, Edgardo; Hortobagyi, Gabriel N; Tran, Hai T

Mutation profiling identifies numerous rare drug targets and distinct mutation patterns in different clinical subtypes of breast cancers.

突变谱分析可识别多种罕见药物靶点和不同临床亚型乳腺癌的独特突变模式

Santarpia Libero, Qi Yuan, Stemke-Hale Katherine, Wang Bailiang, Young Elliana J, Booser Daniel J, Holmes Frankie A, O'Shaughnessy Joyce, Hellerstedt Beth, Pippen John, Vidaurre Tatiana, Gomez Henry, Valero Vicente, Hortobagyi Gabriel N, Symmans W Fraser, Bottai Giulia, Di Leo Angelo, Gonzalez-Angulo Ana M, Pusztai Lajos

A genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancer

基因组预测因子可用于预测浸润性乳腺癌患者接受紫杉烷-蒽环类化疗后的疗效和生存期

Hatzis, Christos; Pusztai, Lajos; Valero, Vicente; Booser, Daniel J; Esserman, Laura; Lluch, Ana; Vidaurre, Tatiana; Holmes, Frankie; Souchon, Eduardo; Wang, Hongkun; Martin, Miguel; Cotrina, José; Gomez, Henry; Hubbard, Rebekah; Chacón, J Ignacio; Ferrer-Lozano, Jaime; Dyer, Richard; Buxton, Meredith; Gong, Yun; Wu, Yun; Ibrahim, Nuhad; Andreopoulou, Eleni; Ueno, Naoto T; Hunt, Kelly; Yang, Wei; Nazario, Arlene; DeMichele, Angela; O'Shaughnessy, Joyce; Hortobagyi, Gabriel N; Symmans, W Fraser

Phase I/II study of trastuzumab in combination with everolimus (RAD001) in patients with HER2-overexpressing metastatic breast cancer who progressed on trastuzumab-based therapy

一项针对接受曲妥珠单抗治疗后病情进展的HER2过表达转移性乳腺癌患者的I/II期研究(RAD001)评估了曲妥珠单抗联合依维莫司的疗效。

Morrow, Phuong K; Wulf, Gerburg M; Ensor, Joe; Booser, Daniel J; Moore, Julia A; Flores, Peter R; Xiong, Yan; Zhang, Siyuan; Krop, Ian E; Winer, Eric P; Kindelberger, David W; Coviello, Jeanna; Sahin, Aysegul A; Nuñez, Rodolfo; Hortobagyi, Gabriel N; Yu, Dihua; Esteva, Francisco J

Phase III randomized trial of dose intensive neoadjuvant chemotherapy with or without G-CSF in locally advanced breast cancer: long-term results

局部晚期乳腺癌患者接受剂量强化新辅助化疗联合或不联合粒细胞集落刺激因子(G-CSF)治疗的III期随机试验:长期结果

Arun, Banu K; Dhinghra, Kapil; Valero, Vicente; Kau, Shu-Wan; Broglio, Kristine; Booser, Daniel; Guerra, Laura; Yin, Guosheng; Walters, Ronald; Sahin, Aysegul; Ibrahim, Nuhad; Buzdar, Aman U; Frye, Debbie; Sneige, Nour; Strom, Eric; Ross, Merrick; Theriault, Richard L; Vadhan-Raj, Saroj; Hortobagyi, Gabriel N